Standardised uptake value with dual time-point FDG-PET/CT in suspected recurrent breast cancer

被引：0
|
作者：
Baun, C. [1 ]
Falch, K. [1 ]
Vestergaard, S. [1 ]
Gerke, O. [1 ]
Hoilund-Carlsen, P. F. [1 ]
Hildebrandt, M. G. [1 ]
机构：
[1] Odense Univ Hosp, DK-5000 Odense, Denmark
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP225
引用
收藏
页码：S197 / S197
页数：1
相关论文
共 50 条
  • [21] Dual-Time-Point FDG-PET/CT for the Detection of Hepatic Metastases
    Albert Dirisamer
    Benjamin S. Halpern
    Wolfgang Schima
    Martin Heinisch
    Florian Wolf
    Mohsen Beheshti
    Franz Dirisamer
    Michael Weber
    Werner Langsteger
    Molecular Imaging and Biology, 2008, 10 : 335 - 340
  • [22] Utility of FDG-PET in suspected recurrent and metastatic prostate cancer
    Jadvar, H
    Kherbache, HM
    Conti, PS
    RADIOLOGY, 2002, 225 : 608 - 608
  • [23] Applications of dual time point imaging and multiple time point FDG-PET/CT in the clinic.
    Houshmand, Sina
    Ziai, Pouya
    Salavati, Ali
    Gholami, Saeid
    Werner, Thomas
    Alavi, Abass
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [24] Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?
    Ahmet Bilici
    Bala Basak Oven Ustaalioglu
    Mesut Seker
    Nesrin Canpolat
    Bulent Tekinsoy
    Taflan Salepci
    Mahmut Gumus
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1259 - 1269
  • [25] Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?
    Bilici, Ahmet
    Ustaalioglu, Bala Basak Oven
    Seker, Mesut
    Canpolat, Nesrin
    Tekinsoy, Bulent
    Salepci, Taflan
    Gumus, Mahmut
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (07) : 1259 - 1269
  • [26] Clinical utility of FDG-PET/CT in patients with suspected recurrence of breast cancer.
    Caresia Aroztegui, A. P.
    Gamez Cenzano, C.
    Cortes Romera, M.
    Robles Barba, J. J.
    Rodriguez Bel, L.
    Rossi Seoane, S.
    Martinez Torrens, F.
    Urruticoechea Ribate, A.
    Moreno Sala, F.
    Gil, J. Gil
    Benitez Segura, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S418 - S418
  • [27] DOES DUAL-POINT FDG-PET/CT IMPROVE DIAGNOSTIC ACCURACY IN THE PREOPERATIVE ASSESSMENT OF SUSPECTED OVARIAN CANCER?
    Vilstrup, M.
    Neumann, G.
    Johnsen, I.
    Asmussen, J.
    Gerke, O.
    Hoilund-Carlsen, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1531 - 1532
  • [28] Clinical value of FDG-PET/CT in suspected vascular graft infection
    Pedersen, K. T.
    Hess, S.
    Vind, S. H.
    Baudier, F.
    Gerke, O.
    Hoilund-Carlsen, P. F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S178 - S178
  • [29] A comparison of the diagnostic value of MRI and FDG-PET/CT in suspected spondylodiscitis
    Kouijzer, Ilse
    Smids, Carolijn
    Vos, Fidel
    Sprong, Tom
    Hosman, Allard
    de Rooy, Jacky
    Bleeker-Rovers, Chantal
    Oyen, Wim
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [30] FDG-PET uptake in breast cancer molecular subtypes
    Elias, Sjoerd G.
    Wisner, Dorota J.
    Chen, Yunn-Yi
    Behr, Spencer C.
    Griffin, Ann
    Esserman, Laura J.
    van't Veer, Laura J.
    Hylton, Nola M.
    CANCER RESEARCH, 2012, 72
12345